Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jacobson

Showing results (421-430 of 792) with videos related to

Pageof 80
Sort By:
Peptides|July 1, 1992
A study of the effect of the irreversible delta receptor antagonist [D-Ala2,Leu5,Cys6]-enkephalin on delta cx and delta ncx opioid binding sites in vitro and in vivoR B Rothman, V Bykov, A E Jacobson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidenceR B Rothman, J B Long, V Bykov, et al.
European Journal of Pharmacology|June 6, 1995
Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinityW D Bowen, B J Vilner, W Williams, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|October 14, 2009
Synthesis of 2-(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenamidoethyl-d(4) Dihydrogen Phosphate, Tetra-deuterated pAEAKejun Cheng, Bijali Saha, A Mahadevan, et al.
Molecular Pharmacology|March 1, 1985
A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding siteR B Rothman, W D Bowen, M Herkenham, et al.
Journal of Medicinal Chemistry|August 20, 1993
Synthesis and binding properties of MK-801 isothiocyanates; (+)-3-isothiocyanato-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten- 5,10-imine hydrochloride: a new, potent and selective electrophilic affinity ligand for the NMDA receptor-coupled phencyclidine binding siteJ T Linders, J A Monn, M V Mattson, et al.
Neuropeptides|June 1, 1985
Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding siteR B Rothman, J A Danks, M Herkenham, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremorKimberly M Miller, Michael S Okun, Hubert F Fernandez, et al.
Brain : a Journal of Neurology|February 21, 2012
Worsening essential tremor following deep brain stimulation: disease progression versus toleranceChristopher G Favilla, David Ullman, Aparna Wagle Shukla, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2023
Early intervention and disease modification in atopic dermatitis-the current state of the field and barriers to progressM E Jacobson, R S Seshadri, R Morimoto, et al.
Pageof 80

Showing results (421-430 of 792) with videos related to

Sort By:
Pageof 80
Peptides|July 1, 1992
A study of the effect of the irreversible delta receptor antagonist [D-Ala2,Leu5,Cys6]-enkephalin on delta cx and delta ncx opioid binding sites in vitro and in vivoR B Rothman, V Bykov, A E Jacobson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidenceR B Rothman, J B Long, V Bykov, et al.
European Journal of Pharmacology|June 6, 1995
Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinityW D Bowen, B J Vilner, W Williams, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|October 14, 2009
Synthesis of 2-(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenamidoethyl-d(4) Dihydrogen Phosphate, Tetra-deuterated pAEAKejun Cheng, Bijali Saha, A Mahadevan, et al.
Molecular Pharmacology|March 1, 1985
A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding siteR B Rothman, W D Bowen, M Herkenham, et al.
Journal of Medicinal Chemistry|August 20, 1993
Synthesis and binding properties of MK-801 isothiocyanates; (+)-3-isothiocyanato-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten- 5,10-imine hydrochloride: a new, potent and selective electrophilic affinity ligand for the NMDA receptor-coupled phencyclidine binding siteJ T Linders, J A Monn, M V Mattson, et al.
Neuropeptides|June 1, 1985
Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding siteR B Rothman, J A Danks, M Herkenham, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremorKimberly M Miller, Michael S Okun, Hubert F Fernandez, et al.
Brain : a Journal of Neurology|February 21, 2012
Worsening essential tremor following deep brain stimulation: disease progression versus toleranceChristopher G Favilla, David Ullman, Aparna Wagle Shukla, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2023
Early intervention and disease modification in atopic dermatitis-the current state of the field and barriers to progressM E Jacobson, R S Seshadri, R Morimoto, et al.
Pageof 80